[Hydrochlorothiazide in the metaphylaxis of recurrent calcium oxalate lithiasis].
The main indication for the application of Disalunil in the convalescent care of recidive calcium-lithiasis patients is renal hypercalciuria. Treatment with 50 mg Disalunil/d reduced the rate of recidivation by two thirds. Even during long-term application of this therapy over 3-7 years, side effects were slight and did not require any cessation of therapy.
D000328:Adult; D002129:Calcium Oxalate / Q000652:urine; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012008:Recurrence; D014545:Urinary Calculi / Q000517:prevention & control* / Q000652:urine
D006852:Hydrochlorothiazide; D002129:Calcium Oxalate; D011188:Potassium
Hydrochlorothiazide in der Metaphylaxe der rezidivierenden Kalzium-oxalatlithiasis.